Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PsyQ Haaglanden Kenniscentrum ADHD bij volwassenen is a specialized clinical and research center focused on Attention Deficit Hyperactivity Disorder (ADHD) in adult populations. Based in The Hague, Netherlands, it operates as part of the PsyQ network under the Parnassia Groep, providing comprehensive diagnostic services and evidence-based treatments. The center is renowned for its expertise in adult ADHD, contributing significantly to scientific research, professional training, and the development of clinical guidelines. Its multidisciplinary approach includes pharmacotherapy, cognitive behavioral therapy, and specialized coaching to improve the quality of life for patients with ADHD and related comorbidities. The center is also known for developing the DIVA-5 diagnostic tool, which is used internationally for adult ADHD assessment. It maintains strong links with academic institutions to bridge the gap between clinical practice and neurobiological research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PsyQ Haaglanden Kenniscentrum ADHD bij volwassenen.